Furthermore, recent evidence suggests that ERO1α upregulation may contribute to increased PD-L1 expression on tumor cells, further dampening T-cell activity and reinforcing immune evasion mechanisms [27]. The gene discussed is ERO1A; the disease is neoplasm.